Centre To Convert 2,000 Agri Societies Into Jan Aushadhi Kendras

New Delhi : The Union government has identified 2,000 primary agricultural credit societies (PACS) to serve as Pradhan Mantri Bhartiya Jan Aushadhi Kendras, which are low-cost pharmacies selling unbranded medicines, which officials said would bolster last-mile health care delivery.

“One thousand centres will start functioning by August and the next 1,000 by December this year,” an official said, declining to be named. The move follows a plan to diversify these farm-service points and an agreement overseen by home minister Amit Shah and health minister Mansukh Mandaviya.

The cooperation ministry, also headed by Shah, is currently ramping up a drive to digitize PACS, which act as last-mile financial institutions for millions of farmers, which will enable them to diversify their business activities.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the chemicals and fertilizers ministry headed by Mandaviya in November 2008 to make quality generic medicines available at affordable prices. These dispensing facilities sell generic drugs that are 50-90% cheaper than branded drugs.

The Centre has rolled out changes to revamp the cooperative sector. At the heart of the overhaul is the plan to digitise PACS. India has nearly 800,000 cooperatives with a total membership base of about 290 million individuals, including banks, sugar mills and businesses, such as fertilizer-maker IFFCO and milk brand Amul. Cooperatives are collectives jointly owned by participating members who share profits and losses.

To be eligible to dispense drugs under the scheme, a primary cooperative society needs at least 120 sq. ft space, either privately owned or rented. The application fee for a Jan Aushadhi Kendra is ₹5,000. Women entrepreneurs, differently abled citizens, and scheduled castes and tribes get priority under special categories. All fees are waived off for applications from the special category, the official said.

  • Related Posts

    • Pharma
    • July 26, 2024
    • 118 views
    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

    • Pharma
    • July 26, 2024
    • 108 views
    Indian National Charged With Selling Counterfeit Cancer Drugs

    HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Indian National Charged With Selling Counterfeit Cancer Drugs

    Indian National Charged With Selling Counterfeit Cancer Drugs

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD